Brief: Skinbiotherapeutics To Finalise Hy26 Results With Restated Fy25 Results After Investigation Review
April 29 (Reuters) - SkinBioTherapeutics PLC SBTX.L: SKINBIOTHERAPEUTICS - UPDATE ON THE FRP INVESTIGATION SKINBIOTHERAPEUTICS PLC - SAYS FRP ADVISORY FORENSIC INVESTIGATION REPORT EXPECTED IN COMING DAYS SKINBIOTHERAPEUTICS PLC - TO FINALISE HY26 RESULTS WITH RESTATED FY25 RESULTS AFTER INVESTIGATION REVIEW Source text: ID:nRSc4466Ca Further company coverage: SBTX.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company